Relative Importance of Cardiovascular Risk Factors and Echocardiographic Parameters Affecting Left Atrial Strain
Launched by YONSEI UNIVERSITY · Nov 26, 2022
Trial Information
Current as of February 05, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a specific measurement called left atrial reservoir strain (LARS) in people who have heart failure with preserved ejection fraction (HFpEF). The researchers want to find out if LARS can help predict the severity of heart failure and how it compares to other traditional risk factors, like blood pressure and cholesterol levels. They hope to better understand how different factors affect heart health, especially for patients with this type of heart failure.
To participate, you need to be at least 20 years old and have a diagnosis of heart failure. However, if you have certain heart conditions, such as a low ejection fraction (less than 50%) or specific heart rhythm issues, you won't be eligible. If you join the study, expect to have your left atrial reservoir strain measured, which is a relatively simple test that helps assess how well your heart is functioning. The trial is currently looking for participants and is open to all genders.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Participants with ICD-10 code of heart failure (I50) from August 2021 to July 2022
- • 20-year-old or higher age
- • Participants who are available to measure left atrial reservoir strain
- Exclusion Criteria:
- • Left ventricular ejection fraction \<50%
- • Supraventricular arrhythmia (e.g. atrial flutter/fibrillation, atrial tachycardia)
- • Participants who are given pacemaker or ICD implantation procedure
About Yonsei University
Yonsei University, a prestigious institution located in South Korea, is renowned for its commitment to advancing medical research and education. As a clinical trial sponsor, Yonsei University leverages its extensive expertise and innovative approaches in various fields of medicine to conduct rigorous clinical trials aimed at improving patient outcomes and advancing healthcare solutions. The university's robust infrastructure, multidisciplinary collaboration, and adherence to ethical standards ensure the integrity and reliability of its research initiatives, making it a key player in the global clinical research landscape.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Yongin, Gyeonggi, Korea, Republic Of
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0
Similar Trials